Doctors test which score best predicts lung disease survival
NCT ID NCT07169253
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study looked at 143 people with two types of lung scarring diseases (IPF and hypersensitivity pneumonitis). Researchers compared three different scoring systems (GAP, ILD-GAP, and CPI) to see which one best predicts how long patients might live. The goal was to find the most accurate tool for doctors to use in everyday care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBROTIC HYPERSENSITIVITY PNEUMONITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital
Istanbul, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which finger or earlobe? a study tests the best spot for oxygen monitoring in lung disease
- Can an inhaled powder stop lung scarring? a safety trial begins
- Repairing lungs from within: stem cells harvested from Patients' own airways tested for scarring disease
- AI could uncover hidden lung disease in routine chest X-Rays
- Can oxygen during exercise supercharge lung rehab for ILD patients?
- Handheld breath test could spot lung disease early